A Proteomics Signature of NASH - Non-Invasive Assessment of Nonalcoholic Fatty Liver Disease
Learn Generative AI, Prompt Engineering, and LLMs for Free
Learn AI, Data Science & Business — Earn Certificates That Get You Hired
Overview
Google, IBM & Meta Certificates – 40% Off
One plan covers every Professional Certificate on Coursera.
Unlock All Certificates
Explore the latest advancements in proteomics for diagnosing and monitoring nonalcoholic steatohepatitis (NASH) in this comprehensive webinar presented by Dr. Arun Sanyal. Delve into the global prevalence of nonalcoholic fatty liver disease (NAFLD) and the urgent need for non-invasive diagnostic tools. Learn about the development and validation of proteomics-based models for assessing key liver biopsy components and at-risk NASH. Discover how these innovative "liquid biopsy" techniques could revolutionize NAFLD assessment, potentially replacing invasive liver biopsies. Gain insights into ongoing clinical trials, disease progression, and effective strategies for managing NASH. Engage with cutting-edge research on serum protein profiling and its implications for diagnosis, prognosis, and monitoring of NAFLD and NASH.
Syllabus
Introduction
Liver Journey
Effective Strategies
Collaborative Project
Data Summary
Disease Progression
Pivence Trial
Flint Study
Clinical Trials
Summary
Live QA
Taught by
Labroots